Respiratory synctial virus (rsv) sequences for protein expression and vaccines
AssigneeUniversity of Massachusetts a University
InventorTrudy G. Morrison
Life of this patent
Estimating the term…
Abstract
The invention provides RSV fusion (F) protein ectodomain polypeptide sequences and nucleotide sequences encoding them, as well as cells containing the invention's polypeptide and nucleotide sequences. The invention further provides VLPs that contain the invention's polypeptides, and methods for using the VLPs for protein expression and vaccine formulation. Also provided are methods for distinguishing between subjects immunized with the invention's compositions and subjects infected with RSV.
Claims35
1-2. (canceled)
A recombinant polypeptide sequence comprising RSV F-LM protein ectodomain SEQ ID NO:16.
4-5. (canceled)
8-10. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
29-30. (canceled)
A recombinant polypeptide sequence comprising a first polypeptide having at least 95% identity to RSV F protein ectodomain polypeptide SEQ ID NO:16, wherein the first polypeptide comprises at least one of (a) lysine at a position corresponding to amino acid 66 of SEQ ID NO:16, (b) glutamine at a position corresponding to amino acid 101 of SEQ ID NO:16, and (c) valine at a position corresponding to amino acid 203 of SEQ ID NO:16.
32-45. (canceled)
47-49. (canceled)
52-55. (canceled)
57-59. (canceled)
Dependencies are inferred from the claim text.